Norda ASA Stock Oslo Bors
Equities
NORD
NO0010285190
Biotechnology & Medical Research
Sales 2021 | 139M 12.67M | Sales 2022 | 128M 11.64M | Capitalization | 204M 18.53M |
---|---|---|---|---|---|
Net income 2021 | 82M 7.46M | Net income 2022 | 100M 9.09M | EV / Sales 2021 | 0.22 x |
Net cash position 2021 | 159M 14.43M | Net cash position 2022 | 257M 23.35M | EV / Sales 2022 | -0.41 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 6.26% |
Managers | Title | Age | Since |
---|---|---|---|
Frode Westvold
CEO | Chief Executive Officer | - | 13-04-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 13-06-19 | |
Chairman | 52 | 12-06-20 | |
Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-19.37% | 11.48B | |
+38.38% | 3.27B | |
-36.56% | 2.2B | |
-18.92% | 2.05B | |
-29.61% | 1.49B | |
+13.89% | 1.01B | |
-4.37% | 743M | |
-35.92% | 413M | |
-48.47% | 377M |